Does Pleural Invasion Lead to Worse Outcomes in Early NSCLC?

United States News News

Does Pleural Invasion Lead to Worse Outcomes in Early NSCLC?
United States Latest News,United States Headlines
  • 📰 Medscape
  • ⏱ Reading Time:
  • 7 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 6%
  • Publisher: 55%

Individuals with small, peripheral, node-negative NSCLC and visceral pleural invasion had higher recurrence rates than those without pleural involvement, but similar overall survival rates.

In patients with small, peripheral non–small cell lung cancer , visceral pleural invasion leads to worse disease-free and recurrence-free survival as well as higher rates of recurrence, regardless of the extent of surgical resection, new data show. However, the presence of visceral pleural invasion does not appear to significantly affect overall survival.

In this post hoc analysis, patients were stratified and compared based on the absence or presence of visceral pleural invasion.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Medscape /  🏆 386. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA Calls AstraZeneca's NSCLC Trial Design Into QuestionFDA Calls AstraZeneca's NSCLC Trial Design Into QuestionThe agency says there's a problem with the latest trial of perioperative immunotherapy for NSCLC: There's no way to tell whether people need to continue treatment after surgery.
Read more »

IASLC Issues Consensus on Neoadjuvant, Adjuvant Treatments in Non–Small Cell Lung CancerIASLC Issues Consensus on Neoadjuvant, Adjuvant Treatments in Non–Small Cell Lung CancerMark Kris discusses adjuvant and neoadjuvant therapy consensus guidelines for NSCLC.
Read more »

Immunotherapy and Survival in Advanced NSCLC: Does Obesity Matter?Immunotherapy and Survival in Advanced NSCLC: Does Obesity Matter?An obesity paradox does exist, but among patients with overweight or obesity, frontline immunotherapy was not associated with a survival benefit compared with chemotherapy, new data suggested.
Read more »

FDA Approves Neoadjuvant/Adjuvant Durvalumab for NSCLCFDA Approves Neoadjuvant/Adjuvant Durvalumab for NSCLCThis approval follows recent concerns from an FDA committee that AstraZeneca did not demonstrate that patients needed the immunotherapy both before and after surgery.
Read more »

California County Warns of 'Painful Pustules' From Aggressive Ant InvasionCalifornia County Warns of 'Painful Pustules' From Aggressive Ant InvasionThese ants 'are highly aggressive in nature, and are capable of biting and stinging humans, pets and livestock,' Santa Barbara County said.
Read more »

Olympics 2024: Morocco beat Argentina amid fan invasion chaosOlympics 2024: Morocco beat Argentina amid fan invasion chaosMorocco fans crashed the pitch to protest a late goal by Argentina at the opening match of the Paris Olympics men's soccer tournament.
Read more »



Render Time: 2025-02-12 13:01:08